HARBOUR INVESTMENTS, INC.

Position in HROW — Harrow, Inc.

CIK 810121 MADISON, WI

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$69,462

-$65,043 QoQ

Shares Held

1,970

-28.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOUR INVESTMENTS, INC. holds $1,485,705 across 37 Drug Manufacturers - Specialty & Generic names. HROW ranks #6 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RMTI	Rockwell Medical, Inc.	33,674	$299,698
2	ZTS	Zoetis Inc.	2,164	$255,806
3	HIMS	Hims & Hers Health, Inc.	10,014	$207,890
4	TAK	Takeda Pharmaceutical Co Ltd	8,107	$150,141
5	VTRS	Viatris Inc	10,434	$140,963
6	HROW	Harrow, Inc. This page	1,970	$69,462
7	HLN	Haleon plc	5,879	$58,848
8	TEVA	Teva Pharmaceutical Industries Ltd	1,553	$46,776

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$69,462	1,970	-28.2%	Shares	Sole	2026-05-15
2025-12-31	$134,505	2,745	-33.8%	Shares	Sole	2026-02-09
2025-09-30	$199,706	4,145	-19.4%	Shares	Sole	2025-11-12
2025-06-30	$157,128	5,145	0.0%	Shares	Sole	2025-07-28
2025-03-31	$136,857	5,145	-32.7%	Shares	Sole	2025-05-08
2024-12-31	$256,489	7,645	0.0%	Shares	Sole	2025-02-10
2024-09-30	$343,719	7,645	0.0%	Shares	Sole	2024-11-04
2024-06-30	$159,704	7,645	0.0%	Shares	Sole	2024-07-26
2024-03-31	$101,143	7,645	0.0%	Shares	Sole	2024-07-22
2023-12-31	$85,624	7,645	0.0%	Shares	Sole	2024-02-16
2023-09-30	$109,858	7,645	0.0%	Shares	Sole	2023-11-15
2023-06-30	$145,560	7,645	-75.8%	Shares	Sole	2023-08-15
2023-03-31	$669,608	31,645	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.